Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1162 (LINC01162) is a human long non-coding RNA (lncRNA) classified as a long intergenic non-coding RNA (lincRNA), which means it is transcribed from genomic regions that do not overlap with protein-coding genes[3][5]. Like other lincRNAs, LINC01162 is thought to regulate gene expression at multiple levels, including transcriptional and epigenetic regulation, but the specific biological functions and disease associations of LINC01162 have not yet been defined in the scientific literature[1][5]. There are no documented drug interactions, clinical roles, or established mechanisms of action directly associated with LINC01162. The molecule is cataloged in public databases as an lncRNA gene but remains largely uncharacterized compared to well-studied lncRNAs like LINC01116, which is implicated in multiple cancers[2][4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1162 (LINC01162).